Publicaciones en las que colabora con Diana Hernandez Romero (7)

2017

  1. Does von Willebrand factor improve the predictive ability of current risk stratification scores in patients with atrial fibrillation?

    Scientific Reports, Vol. 7

2013

  1. The prognostic role of the adiponectin levels in atrial fibrillation

    European Journal of Clinical Investigation, Vol. 43, Núm. 2, pp. 168-173

2012

  1. Valor predictivo de la escala CHA 2DS 2-VASc en pacientes con fibrilación auricular de alto riesgo embólico en tratamiento anticoagulante

    Revista Espanola de Cardiologia, Vol. 65, Núm. 7, pp. 627-633

2011

  1. Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients

    Journal of the American College of Cardiology, Vol. 57, Núm. 25, pp. 2496-2504

2010

  1. CALU A29809G polymorphism in coronary atherothrombosis: Implications for coronary calcification and prognosis

    Annals of Medicine, Vol. 42, Núm. 6, pp. 439-446

  2. Synergism between factor XII -4C>T and factor XIII Val34Leu polymorphisms in fibrinolytic therapy in acute myocardial infarction

    Thrombosis and Haemostasis

2009

  1. Implications of pharmacogenetics for oral anticoagulants metabolism

    Current Drug Metabolism, Vol. 10, Núm. 6, pp. 632-642